Balaji Amines Limited Stock

Equities

BALAMINES

INE050E01027

Specialty Chemicals

Market Closed - Bombay S.E. 06:00:47 2024-04-23 am EDT 5-day change 1st Jan Change
2,228 INR +1.70% Intraday chart for Balaji Amines Limited +0.04% -16.51%
Sales 2024 * 16.44B 198M Sales 2025 * 20.8B 250M Capitalization 72.18B 867M
Net income 2024 * 2.02B 24.31M Net income 2025 * 2.96B 35.6M EV / Sales 2024 * 4.39 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 3.47 x
P/E ratio 2024 *
35.7 x
P/E ratio 2025 *
24.3 x
Employees 1,111
Yield 2024 *
-
Yield 2025 *
-
Free-Float 30.74%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.70%
1 week+0.04%
Current month+9.00%
1 month+5.67%
3 months-5.64%
6 months+6.17%
Current year-16.51%
More quotes
1 week
2 150.00
Extreme 2150
2 258.05
1 month
2 028.95
Extreme 2028.95
2 326.00
Current year
2 010.00
Extreme 2010
2 716.50
1 year
1 872.90
Extreme 1872.9
2 736.35
3 years
1 872.90
Extreme 1872.9
5 220.00
5 years
204.10
Extreme 204.1
5 220.00
10 years
40.85
Extreme 40.85
5 220.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 89-01-14
Chairman 72 88-10-26
Director of Finance/CFO 48 13-05-10
Members of the board TitleAgeSince
Director/Board Member 69 88-10-26
Chief Executive Officer 62 89-01-14
Director/Board Member 58 23-05-19
More insiders
Date Price Change Volume
24-04-23 2,228 +1.70% 6,852
24-04-22 2,191 +0.82% 6,973
24-04-19 2,173 -1.40% 3,117
24-04-18 2,204 -1.04% 4,006
24-04-16 2,227 +1.46% 8,716

Delayed Quote Bombay S.E., April 23, 2024 at 06:00 am EDT

More quotes
Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals, aliphatic amines and derivatives. The Company’s segments include Amines & Specialty Chemicals and Hotel Division. It also owns a five-star Hotel in Solapur, Maharashtra. Its products include amines, derivatives, specialty chemicals and pharma excipients. Its amine products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA), TRIMETHYLAMINE and others. Its specialty chemical products include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and others. Its derivatives products include Di-Methyl Acetamide (DMAC); Di-Methyl Amine Hydrochloride (DMA HCL); Tri-Methyl Amine Hydrochloride (TMA HCL); Di-Ethyl Amine Hydrochloride (DEA HCL), and others. Its pharma excipients products include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,228 INR
Average target price
2,742 INR
Spread / Average Target
+23.08%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BALAMINES Stock